// App-Quantinova.ai

132 : Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Ryan Dittamore

Principal Investigators

  • Jessica Louw

  • Rachel Krupa

  • Aseem Anand

  • Daniel Costin Danila

  • Zaina Arslan

  • Natalee Bales

  • Dena Marrinucci

  • Howard I. Scher

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Epic Sciences, Inc., La Jolla, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Phosphatase and tensin homolog

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Prostate specific antigen

  • ETS transcription factor ERG

Drug/Treatment

  • Enzalutamide

  • CB-7598

  • Prednisone

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved